Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk PredictionMarina Marchetti, Patricia Gomez-Rosas, Eleonora Sanga, et al.Haematologica|August 11, 2019
An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimensFrancesca Schieppati, Piera Balzarini, Simona Fisogni, et al.Cancer|February 2, 2019
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitorsMariella D'Adda, Mirko Farina, Francesca Schieppati, et al.American Journal of Hematology|May 1, 2020
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional studyFrancesca Schieppati, Laura Russo, Marina Marchetti, et al.Frontiers in Cardiovascular Medicine|June 27, 2022
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 PatientsMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasmsSarah Kelliher, Sara Gamba, Luisa Weiss, et al.Hematological Oncology|September 19, 2020
Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemiaErika Borlenghi, Chiara Cattaneo, Elisa Cerqui, et al.Cancers|August 28, 2025
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During ChemotherapyMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.Cancers|September 23, 2022
Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal CancerCinzia Giaccherini, Cristina Verzeroli, Laura Russo, et al.Journal of Thrombosis and Haemostasis : JTH|September 7, 2025
Management of recurrent venous thromboembolism during anticoagulant treatment in patients with cancer: a prospective cohort studyVincent R Lanting, Floris T M Bosch, Emily S L Martens, et al.Pageof 3